Deal Announcements

Direct Flow Medical Clears $27 Million Series B

Monday, October 22, 2007 5:00:00 AM PDT | VentureDeal Staff

SANTA ROSA, CA -- Medical device maker Direct Flow Medical said that it has completed its second round of venture capital financing, receiving $27 million from a syndicate of firms and strategic investors.

Direct Flow is developing a percutaneous aortic tissue valve prosthesis that provides patients with a safer way to treat cardiac valve conditions.  The prosthesis can be placed using a minimally-invasive procedure.

Investors were led by Johnson & Johnson Development Corporation and Foundation Medical Partners, and included VantagePoint Venture Partners, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1